The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice

Mark Heffernan, Roger J. Summers, Anne Thorburn, Esra Ogru, Robert Gianello, Woei Jia Jiang, Frank M. Ng

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Both human GH (hGH) and a lipolytic fragment (AOD9604) synthesized from its C-terminus are capable of inducing weight loss and increasing lipolytic sensitivity following long-term treatment in mice. One mechanism by which this may occur is through an interaction with the β-adrenergic pathway, particularly with the β3-adrenergic receptors (β3-AR). Here we describe how hGH and AOD9604 can reduce body weight and body fat in obese mice following 14 d of chronic ip administration. These results correlate with increases in the level of expression of β3-AR RNA, the major lipolytic receptor found in fat cells. Importantly, both hGH and AOD9604 are capable of increasing the repressed levels of β3-AR RNA in obese mice to levels comparable with those in lean mice. The importance of β3-AR was verified when long-term treatment with hGH and AOD9604 in β3-AR knock-out mice failed to produce the change in body weight and increase in lipolysis that was observed in wild-type control mice. However, in an acute experiment, AOD9604 was capable of increasing energy expenditure and fat oxidation in the β3-AR knock-out mice. In conclusion, this study demonstrates that the lipolytic actions of both hGH and AOD9604 are not mediated directly through the β3-AR although both compounds increase β3-AR expression, which may subsequently contribute to enhanced lipolytic sensitivity.

Original languageEnglish
Pages (from-to)5182-5189
Number of pages8
JournalEndocrinology
Volume142
Issue number12
DOIs
Publication statusPublished - 1 Jan 2001

Cite this

Heffernan, Mark ; Summers, Roger J. ; Thorburn, Anne ; Ogru, Esra ; Gianello, Robert ; Jiang, Woei Jia ; Ng, Frank M. / The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice. In: Endocrinology. 2001 ; Vol. 142, No. 12. pp. 5182-5189.
@article{e6ecb8e93a3141b58785a4304c5e529e,
title = "The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice",
abstract = "Both human GH (hGH) and a lipolytic fragment (AOD9604) synthesized from its C-terminus are capable of inducing weight loss and increasing lipolytic sensitivity following long-term treatment in mice. One mechanism by which this may occur is through an interaction with the β-adrenergic pathway, particularly with the β3-adrenergic receptors (β3-AR). Here we describe how hGH and AOD9604 can reduce body weight and body fat in obese mice following 14 d of chronic ip administration. These results correlate with increases in the level of expression of β3-AR RNA, the major lipolytic receptor found in fat cells. Importantly, both hGH and AOD9604 are capable of increasing the repressed levels of β3-AR RNA in obese mice to levels comparable with those in lean mice. The importance of β3-AR was verified when long-term treatment with hGH and AOD9604 in β3-AR knock-out mice failed to produce the change in body weight and increase in lipolysis that was observed in wild-type control mice. However, in an acute experiment, AOD9604 was capable of increasing energy expenditure and fat oxidation in the β3-AR knock-out mice. In conclusion, this study demonstrates that the lipolytic actions of both hGH and AOD9604 are not mediated directly through the β3-AR although both compounds increase β3-AR expression, which may subsequently contribute to enhanced lipolytic sensitivity.",
author = "Mark Heffernan and Summers, {Roger J.} and Anne Thorburn and Esra Ogru and Robert Gianello and Jiang, {Woei Jia} and Ng, {Frank M.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1210/endo.142.12.8522",
language = "English",
volume = "142",
pages = "5182--5189",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "Endocrine Society",
number = "12",

}

The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice. / Heffernan, Mark; Summers, Roger J.; Thorburn, Anne; Ogru, Esra; Gianello, Robert; Jiang, Woei Jia; Ng, Frank M.

In: Endocrinology, Vol. 142, No. 12, 01.01.2001, p. 5182-5189.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice

AU - Heffernan, Mark

AU - Summers, Roger J.

AU - Thorburn, Anne

AU - Ogru, Esra

AU - Gianello, Robert

AU - Jiang, Woei Jia

AU - Ng, Frank M.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Both human GH (hGH) and a lipolytic fragment (AOD9604) synthesized from its C-terminus are capable of inducing weight loss and increasing lipolytic sensitivity following long-term treatment in mice. One mechanism by which this may occur is through an interaction with the β-adrenergic pathway, particularly with the β3-adrenergic receptors (β3-AR). Here we describe how hGH and AOD9604 can reduce body weight and body fat in obese mice following 14 d of chronic ip administration. These results correlate with increases in the level of expression of β3-AR RNA, the major lipolytic receptor found in fat cells. Importantly, both hGH and AOD9604 are capable of increasing the repressed levels of β3-AR RNA in obese mice to levels comparable with those in lean mice. The importance of β3-AR was verified when long-term treatment with hGH and AOD9604 in β3-AR knock-out mice failed to produce the change in body weight and increase in lipolysis that was observed in wild-type control mice. However, in an acute experiment, AOD9604 was capable of increasing energy expenditure and fat oxidation in the β3-AR knock-out mice. In conclusion, this study demonstrates that the lipolytic actions of both hGH and AOD9604 are not mediated directly through the β3-AR although both compounds increase β3-AR expression, which may subsequently contribute to enhanced lipolytic sensitivity.

AB - Both human GH (hGH) and a lipolytic fragment (AOD9604) synthesized from its C-terminus are capable of inducing weight loss and increasing lipolytic sensitivity following long-term treatment in mice. One mechanism by which this may occur is through an interaction with the β-adrenergic pathway, particularly with the β3-adrenergic receptors (β3-AR). Here we describe how hGH and AOD9604 can reduce body weight and body fat in obese mice following 14 d of chronic ip administration. These results correlate with increases in the level of expression of β3-AR RNA, the major lipolytic receptor found in fat cells. Importantly, both hGH and AOD9604 are capable of increasing the repressed levels of β3-AR RNA in obese mice to levels comparable with those in lean mice. The importance of β3-AR was verified when long-term treatment with hGH and AOD9604 in β3-AR knock-out mice failed to produce the change in body weight and increase in lipolysis that was observed in wild-type control mice. However, in an acute experiment, AOD9604 was capable of increasing energy expenditure and fat oxidation in the β3-AR knock-out mice. In conclusion, this study demonstrates that the lipolytic actions of both hGH and AOD9604 are not mediated directly through the β3-AR although both compounds increase β3-AR expression, which may subsequently contribute to enhanced lipolytic sensitivity.

UR - http://www.scopus.com/inward/record.url?scp=0035210333&partnerID=8YFLogxK

U2 - 10.1210/endo.142.12.8522

DO - 10.1210/endo.142.12.8522

M3 - Article

VL - 142

SP - 5182

EP - 5189

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 12

ER -